Press Releases July 16, 2026 08:30 AM

Bel Fuse Schedules Second Quarter 2026 Financial Results Conference Call

Bel Fuse announces date for Q2 2026 financial results and earnings call.

By Ajmal Hussain
Share
Twitter Reddit Facebook LinkedIn
BELFA BELFB

Bel Fuse Inc., a global provider of critical electronic components for aerospace, defense, industrial, and data-driven markets, plans to release its preliminary second quarter 2026 financial results on July 29, 2026, after market close. The company will hold a conference call for investors and analysts on July 30, 2026, to discuss the results.

Bel Fuse Schedules Second Quarter 2026 Financial Results Conference Call
BELFA BELFB
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Bel Fuse operates in high-reliability electronics for aerospace, defense, industrial, and data-driven sectors, impacting those industries.
  • The company has scheduled a Q2 2026 earnings announcement and conference call to provide updates on financial performance.
  • Bel Fuse supports OEMs with customized and standard electronic components, indicating ongoing partnership in innovation and manufacturing.

WEST ORANGE, N.J., July 16, 2026 (GLOBE NEWSWIRE) -- Bel Fuse Inc. (Nasdaq: BELFA and BELFB), a global designer, manufacturer, and provider of critical electronic components, systems and solutions for customers in aerospace, defense, industrial, and data-driven markets, today announced plans to release preliminary financial results for the second quarter after market close on Wednesday, July 29, 2026. An earnings conference call has been scheduled as follows:

When:Thursday, July 30, 2026 at 8:30 a.m. ET  Dial in:877.407.0784, or international: 201.689.8560  Online:https://ir.belfuse.com/events-and-presentations  How:Live over the internet – Simply log on to the web at the address above  Replay:844.512.2921, or international: 412.317.6671   Conference ID: 13761209  

A replay will be available after 12:30 p.m. ET for 30 days following the call.

About Bel
Bel (www.belfuse.com) designs, manufactures, and markets critical electronic components, systems and solutions for customers in aerospace, defense, industrial, and data-driven markets. Understanding that our customers face increasingly complex technical challenges, Bel delivers a comprehensive portfolio of solutions including power systems, high-reliability connectors and cable assemblies, circuit protection, and networking products that enable Original Equipment Manufacturers (OEMs) to bring their innovations to market. Bel partners closely with customers to deliver both customized and standard solutions tailored to their specific applications and performance requirements. With manufacturing facilities and technical support teams worldwide, Bel serves as a strategic partner to customers who require proven reliability in demanding end markets.

Contacts:
Bel Fuse Inc.

Lynn Hutkin, CFO
[email protected]

Three Part Advisors
Jean Marie Young, Managing Director
Steven Hooser, Partner
[email protected]
[email protected]


Risks

  • Financial results might not meet market expectations, potentially impacting the stock price negatively.
  • Dependence on highly regulated sectors such as aerospace and defense introduces risk from government contracts and regulatory changes.
  • Global manufacturing and supply chain challenges could affect timely delivery and costs, impacting profitability.

More from Press Releases

Acoramidis Demonstrates Reversal of Cardiac Structural Disease Progression and Functional Decline and Significantly Increases Days Alive and Free from Hospitalization in ATTR-CM Aug 30, 2026 Cytokinetics Announces Additional Results from ACACIA-HCM and MAPLE-HCM Presented in Late Breaking Clinical Trial Session at the European Society of Cardiology (ESC) Congress 2026 Aug 29, 2026 Tenax Therapeutics Announces Presentation of Phase 3 LEVEL Results in Late-Breaking Scientific Sessions at ESC Congress 2026 Aug 29, 2026 20/20 BioLabs Reschedules Investor Webinar to 2:00 p.m. Eastern Time on September 2, 2026 to Discuss OneTest™ Revenue and Expanding Commercial Opportunity Aug 28, 2026 Trinity Biotech Provides Diagnostics Business, Transformation And Corporate Update Aug 28, 2026